Follicular lymphoma: 2020 update on diagnosis and management

A Freedman, E Jacobsen - American journal of hematology, 2020 - Wiley Online Library
Disease overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is …

CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products

JC Chavez, C Bachmeier… - Therapeutic …, 2019 - journals.sagepub.com
Adoptive cellular immunotherapy with chimeric antigen receptor (CAR) T cell has changed
the treatment landscape of B-cell non-Hodgkin's lymphoma (NHL), especially for aggressive …

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

BD Cheson, RI Fisher, SF Barrington… - Journal of clinical …, 2014 - ascopubs.org
The purpose of this work was to modernize recommendations for evaluation, staging, and
response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma …

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group

SF Barrington, NG Mikhaeel, L Kostakoglu… - Journal of clinical …, 2014 - ascopubs.org
Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …

Follicular lymphoma: 2023 update on diagnosis and management

E Jacobsen - American Journal of Hematology, 2022 - Wiley Online Library
Abstract Disease Overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

Baseline metabolic tumor volume predicts outcome in high–tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies

M Meignan, AS Cottereau, A Versari… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Identifying patients at high risk of progression and early death among those with
high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current prognostic models …

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas

SF Barrington, R Kluge - European journal of nuclear medicine and …, 2017 - Springer
Abstract PET using 18 F-FDG for treatment monitoring in patients with lymphoma is one of
the most well-developed clinical applications. PET/CT is nowadays used during treatment to …

Positron emission tomography (PET) in oncology

A Gallamini, C Zwarthoed, A Borra - Cancers, 2014 - mdpi.com
Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

SF Barrington, AA Kirkwood… - Blood, The Journal …, 2016 - ashpublications.org
International guidelines recommend that positron emission tomography-computed
tomography (PET-CT) should replace CT in Hodgkin lymphoma (HL). The aims of this study …

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised …

J Trotman, SF Barrington, D Belada, M Meignan… - The Lancet …, 2018 - thelancet.com
Background Initial results from the ongoing GALLIUM trial have shown that patients with
follicular lymphoma have a longer progression-free survival after first-line …